Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

OBJECTIVE: The aim of this study was to compare the incidence of cancer and all-cause and cause-specific mortality rates among a cohort of patients with severe PsA receiving TNF inhibitor (TNFi) with those of the general UK population. METHODS: Cancers and deaths were identified from the national ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Rheumatology (Oxford)
Egile Nagusiak: Fagerli, Karen M, Kearsley-Fleet, Lianne, Mercer, Louise K, Watson, Kath, Packham, Jon, Symmons, Deborah P M, Hyrich, Kimme L
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Clinical Science
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6293477/
https://ncbi.nlm.nih.gov/pubmed/30137485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/key241
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak